Author: user

[ad_1] We recently published a list of 8 Best Low Volatility Stocks To Buy Right Now. In this article, we are going to take a look at where Walmart Inc. (NYSE:WMT) stands against other best low volatility stocks to buy right now. The market has shown strong performance overall, with the S&P 500 up nearly 26% year to date. However, in the past thirty days, it has experienced a slight decline of 1%. A notable sell-off occurred between December 17 and 19, which contributed to some volatility. Since then, the market has been fluctuating, with prices rising and falling as…

Read More

[ad_1] 2024 was an eventful year for personal finance. During the year, more people invested in equity mutual funds through systematic investment plans (SIPs). The number of dematerialised (demat) accounts—required for holding shares and other securities electronically—also increased by 22%. As of September 2024, total demat accounts reached 175.4 million, increasing by around 4 million per month since the start of the year. There were also several regulatory changes, trends, and new financial product launches that will affect how you manage your money in the coming years. While it’s not easy to recap the entire year in a single article,…

Read More

[ad_1] Image source: Getty Images I’m searching for the best FTSE 100 dividend stocks to buy at the start of 2025. Here are two I wouldn’t touch with a bargepole next month. Land Securities 2024’s been a poor year for Land Securities (LSE:LAND). Like other real estate investment trusts (REITs), its share price has slumped as investor hopes over swingeing interest rate rises in the new year have declined. This poses a significant risks for property stocks, by keeping net asset values (NAVs) depressed and inflating borrowing costs. It’s a particular problem for Landsec given its high net debt (which…

Read More

[ad_1] In a recent transaction, John Alexander Kelly, the Chief Financial Officer of Precision BioSciences Inc . (NASDAQ:), purchased 2,113 shares of the company’s common stock. The shares were acquired at a price of $4.75 each, amounting to a total transaction value of $10,036. Following this purchase, Kelly’s total holdings in the company increased to 40,186 shares. The transaction was executed on December 27, 2024, according to the SEC filing.This insider purchase comes as the stock trades near its 52-week low of $4.13, with InvestingPro data indicating the stock is currently in oversold territory. The company’s shares have declined over…

Read More

[ad_1] When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right business to buy shares in, you can make more than you can lose. Take, for example Wolverine World Wide, Inc. (NYSE:WWW). Its share price is already up an impressive 148% in the last twelve months. It’s also good to see the share price up 30% over the last quarter. In contrast, the longer term returns are negative, since the share price is 25% lower than it was three years ago. Now it’s worth having a…

Read More

[ad_1] By Michael Erman NEW YORK (Reuters) – Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer (NYSE:) COVID-19 treatment Paxlovid, Bristol Myers (NYSE:) Squibb’s cancer cell therapies and vaccines from France’s Sanofi (NASDAQ:) at the start of 2025, according to data analyzed by healthcare research firm 3 Axis Advisors. Nearly all of the drug price increases are below 10% – most well below. The median price increase of the drugs being hiked Jan. 1 is 4.5%, which is in line with the median for all price increases last year. The increases are to list…

Read More

[ad_1] https://www.tipranks.com/news/company-announcements/aix-inc-finalizes-major-share-exchange-with-bgm-group An announcement from Fanhua ( (AIFU) ) is now available. AIX Inc. has completed a significant share exchange transaction with BGM Group Ltd., transferring its equity interests in RONS Intelligent Technology, Shenzhen Xinbao Investment Management, and its subsidiaries to BGM in exchange for a substantial stake in BGM. This transaction results in AIX owning 72% of BGM’s ordinary shares and aims to enhance innovation and development in the intelligent insurance platform by leveraging BGM’s resources in the global healthcare sector. More about Fanhua YTD Price Performance: -82.93% Average Trading Volume: 282,174 Technical Sentiment Consensus Rating: Buy Current Market…

Read More

[ad_1] Image source: International Airline Group British Airways feels a long way from being the self-styled “world’s favourite airline” these days. But the flag carrier’s parent International Consolidated Airlines (LSE: IAG) has certainly gained altitude this year. Since the beginning of 2024, the IAG share price has skyrocketed by 93%. Sure, it is still 30% lower now than it was five years ago, before pandemic-era travel restrictions ravaged demand for civil aviation. But the price is far above its lows of recent years – it has more than tripled since September 2022 – and the dividend is back. Despite the…

Read More

[ad_1] Zivo Bioscience, Inc. (NASDAQ:ZIVO) recently reported a significant stock acquisition by a major shareholder. Mark E. Strome, through Strome Investment Management LP and Strome Group, Inc., acquired 75,000 shares of Zivo Bioscience’s common stock on December 26, 2024, at a price of $20.19 per share, totaling approximately $1.51 million. The stock, which has delivered an impressive 1,640% return year-to-date according to InvestingPro data, currently trades near $20.89 and appears slightly undervalued based on Fair Value analysis. This transaction increases the total shares owned by the reporting entities to 398,683. Additionally, a related transaction involved the acquisition of 7,500 common…

Read More

[ad_1] Dmitry Balyasny and Steve Schurr, a senior portfolio manager, discussed the firm’s equities rebuild.Balyasny has been leading the unit since Jeff Runnfeldt’s departure in October 2023.The manager wants its equities teams to focus on deep research, not short-term trading.Throughout its 23-year history, Dmitry Balyasny’s firm has been known, first and foremost, as a stock picker.While the $20 billion multistrategy firm has added strategies like macro, commodities, and quant over the years and expanded its head count to 2,000 people, the Chicago-based manager still leads with its equities expertise.So when the firm’s equities teams were dragging the manager’s performance down…

Read More